| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.04 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.099 | 0.05 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.05 |